openPR Logo
Press release

Single-use Bioprocessing Systems Market Players Focusing on Innovative Treatment Solutions to Gain a Competitive Edge: Thermo Fisher Scientific, Danaher Corporation, GE Healthcare, Sartorius Stedim Biotech S.A, Merck Millipore

04-11-2019 08:03 AM CET | Health & Medicine

Press release from: Allied Market Research

Single-use Bioprocessing Market

Single-use Bioprocessing Market

The demand for single-use bioprocessing technology has witnessed an increase over the years, owing to the rise in demand for continuous bio-production in the biopharmaceutical industries. Various market players constantly strive to develop innovative treatment solutions; hence, focus on adopting novel single-use bioprocessing technologies. The continuous demand for single use systems boost the market growth.

According to a new report published by Allied Market Research, titled, "Single-use Bioprocessing Market by Product, Application, Method, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global single-use bioprocessing market was valued at $2,800 million in 2016, and is projected to reach $9,342 million by 2023, growing at a CAGR of 18.7% from 2017 to 2023. The media bags & containers segment accounted for one-fourth share of the global market in 2016.

Asia-Pacific witnessed highest growth rate for single-use bioprocessing market, and is expected to continue this trend throughout the forecast period attributed to the rise in expenditure on healthcare and improvement in medical and healthcare infrastructure. In addition, the key market players focus on the opportunities offered by the growing demand for single-use bioprocess systems. This system is highly cost-effective, which has gained popularity among end users. Moreover, significant growth of pharmaceutical and the biotechnology industries supplements the market growth.

Download Sample PDF Brochure at: https://www.alliedmarketresearch.com/request-sample/2359

The key players operating in the single-use bioprocessing market have adopted product launch as their key developmental strategy and focus on launching innovative products to cater to the consumer requirements and strengthen their market share. The major companies profiled in the report include Thermo Fisher Scientific, Danaher Corporation, GE Healthcare (General Electric Company), Sartorius Stedim Biotech S.A, Merck Millipore (Merck Group), 3M Company, Eppendorf AG, Finesse Solutions, Inc., Applikon Biotechnology B.V., and Cesco Bioengineering Co., Ltd.

Single-use bioprocessing technology has gained significant traction in the recent years, owing to the rapid adoption of disposable bioprocessing equipment by pharmaceutical manufacturers. These products have also proved beneficial for the small scale pharmaceutical manufacturers. Hence, most biopharmaceutical companies utilize single-use bioprocessing technology for manufacturing vaccines, monoclonal antibodies, and other pharmaceutical components on commercial scale.

Rise in adoption of single use technologies, lower risk of product cross-contamination, and less floor space requirement drive the single-use bioprocessing market. In addition, single-use bioprocessing technologies are highly efficient and cost-effective, which attracts the pharmaceutical manufacturers to adopt disposable bioprocessing products, thus propelling the demand for single-use bioprocessing technologies. However, extractability and leachability issues and stringent regulations restrain the market growth. Moreover, untapped markets, such as China and India, offers profitable opportunities for the expansion of this market.

Do Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/2359

The filtration segment generated highest revenue exhibiting one-third of the total share of the single-use bioprocessing market in 2016. Single-use bioprocessing technology penetrated in the pharmaceutical industry through disposable filtration systems and is the crucial part of bioprocessing procedure.

This leads to the high demand for single use filtration products catering to the market growth. In addition, single-use bioprocessing systems are employed in the production of monoclonal antibody production (mAb), making it a leading application of single-use bioprocessing market. The mAb application accounted for two-fifths of the global single-use bioprocessing market in 2016.

However, utilization of single-use bioprocessing systems in patient specific cell therapies has gained momentum in the recent year, and is expected to maintain this trend in the near future with the highest CAGR of 19.9% from 2017 to 2023. Moreover, the biopharmaceutical manufacturers segment accounted for approximately half of the total market share among all the end users of the global single-use bioprocessing market.

About us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David C
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Single-use Bioprocessing Systems Market Players Focusing on Innovative Treatment Solutions to Gain a Competitive Edge: Thermo Fisher Scientific, Danaher Corporation, GE Healthcare, Sartorius Stedim Biotech S.A, Merck Millipore here

News-ID: 1698664 • Views: 284

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Bioprocessing

Bioprocessing Systems Market Higher Mortality Rates by 2025
Manufacturing biologics is a complicated process and thus generally are outsourced by the manufacturers. Bioprocessing is the manufacturing process which helps in producing bio-based products such as vegetable oils, and fatty acids. The major applications of bioprocess industry are vaccines, tissue engineering, biosensors, and biopharmaceuticals. Bioprocessing also is known as biopharmaceutical manufacturing is a bioprocess used for the production of therapeutic cells. Bioprocessing systems thus are in high demand due
Bioprocessing Systems Market with Current Trends Analysis, 2017-2025
Global Bioprocessing Systems: Market Overview Manufacturing biologics is a complicated process and thus generally are outsourced by the manufacturers. Bioprocessing is the manufacturing process which helps in producing bio-based products such as vegetable oils, and fatty acids. The major applications of bioprocess industry are vaccines, tissue engineering, biosensors, and biopharmaceuticals. Bioprocessing also is known as biopharmaceutical manufacturing is a bioprocess used for the production of therapeutic cells. Bioprocessing systems thus are
Bioprocessing Systems Market to Perceive Substantial Growth During 2025
Global Bioprocessing Systems: Market Overview Manufacturing biologics is a complicated process and thus generally are outsourced by the manufacturers. Bioprocessing is the manufacturing process which helps in producing bio-based products such as vegetable oils, and fatty acids. The major applications of bioprocess industry are vaccines, tissue engineering, biosensors, and biopharmaceuticals. Bioprocessing also is known as biopharmaceutical manufacturing is a bioprocess used for the production of therapeutic cells. Bioprocessing systems thus are
Single-use Bioprocessing Market Positive Long-Term Growth Outlook 2023
Global Single-use Bioprocessing Market Research Report 2018” and is available for sale on the company website. The report forecasts the global market to expand at a steady pace over the next few years. The moderate growth observed by the market will be propelled by the gradual shift of consumers towards the latest technological inventions, as it makes an excellent source. Top Key Vendors: Thermo Fisher Scienctific (U.S.), Danaher Corporation (U.S.),
Single-use Bioprocessing Market by Product, Application & End User
Single-use Bioprocessing Market By Product (Media Bags And Containers, Filtration Assemblies, Single-use Bioreactors, Disposable Mixers And Others), By Application (Filtration, Storage, Cell Culture, Mixing And Purification), By End User (Research And Development Institutes And Biopharmaceutical Manufacturers) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021) The Global Single-use Bioprocessing Market was worth USD 2.42 billion in 2016 and estimated to be growing at a CAGR of
Single-Use Bioprocessing Systems Market 2017
The Global Single-use Bioprocessing Market was worth USD 2.42 billion in 2016 and estimated to be growing at a CAGR of 17.5%, to reach USD 5.42 Billion by 2021. The market is showcasing substantia; potential in future years and is expected to continue its growth. Single-use bioprocessing technology is majorly utilized in the manufacturing of biopharmaceuticals. The technique is used throughout the complete process of biopharmaceutical production, right from buffer and media